Series A brings in $31mm for Tobira
Executive Summary
Tobira Therapeutics (developing HIV compounds) raised $31mm in its Series A financing. Domain Associates and Frazier Healthcare Ventures co-led the round and were joined by Montreux Equity Partners and Canaan Partners.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice